Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

COX

Cox Communications (COX)

Cox Comm CL A SC23
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:COX
DateTimeSourceHeadlineSymbolCompany
06/15/20158:50AMDow Jones NewsCox Automotive to Buy Dealertrack for $3.5 BillionNYSE:COXCox Comm CL A SC23
04/27/20155:10PMDow Jones NewsTime Warner Cable Adviser Contacts Rival Cox--UpdateNYSE:COXCox Comm CL A SC23
04/17/201512:42AMGlobeNewswire Inc.Nicox first quarter 2015 financial and business updateNYSE:COXCox Comm CL A SC23
03/30/201512:40AMGlobeNewswire Inc.Nicox 2014 Financial Results and Business UpdateNYSE:COXCox Comm CL A SC23
03/19/20151:37AMGlobeNewswire Inc.Nicox receives Orphan Drug Designation from FDA for naproxcinod in Duchenne Muscular DystrophyNYSE:COXCox Comm CL A SC23
02/02/201512:41AMGlobeNewswire Inc.Nicox signs exclusive license agreement with InSite Vision for AzaSite(R) and BromSite(TM) in EuropeNYSE:COXCox Comm CL A SC23
01/26/201512:35AMGlobeNewswire Inc.Nicox holds successful pre-NDA meeting with FDA on AC-170 clinical packageNYSE:COXCox Comm CL A SC23
07/17/201412:36AMGlobeNewswire Inc.Nicox gains expanded North American rights for Sjo(TM) from Immco DiagnosticsNYSE:COXCox Comm CL A SC23
07/10/201412:35AMGlobeNewswire Inc.Nicox focuses US operations on national launches of Sjo(TM) and RetnaGene(TM) and restructures RPS(R) licensing agreementNYSE:COXCox Comm CL A SC23
07/02/201412:38AMGlobeNewswire Inc.Nicox to acquire Aciex Therapeutics, Inc.NYSE:COXCox Comm CL A SC23
06/30/201412:36AMGlobeNewswire Inc.Nicox launches commercial operations in GermanyNYSE:COXCox Comm CL A SC23
06/19/201412:38AMGlobeNewswire Inc.Nicox and Sequenom announce the launch of expanded access to RetnaGene(TM) test portfolio in the U.S.NYSE:COXCox Comm CL A SC23
05/30/201412:35AMGlobeNewswire Inc.CORRECTED RELEASE - Nicox: Santen grants Eupharmed extension of exclusive rights to distribute Cationorm(R) in ItalyNYSE:COXCox Comm CL A SC23
05/28/201412:36AMGlobeNewswire Inc.Nicox: Santen grants Eupharmed extension of exclusive rights to distribute Cationorm(R) in ItalyNYSE:COXCox Comm CL A SC23
05/15/201410:49AMGlobeNewswire Inc.Nicox: first quarter 2014 financial informationNYSE:COXCox Comm CL A SC23
04/02/201412:41AMGlobeNewswire Inc.Nicox 2013 Financial Results and Business UpdateNYSE:COXCox Comm CL A SC23
03/17/20141:35AMGlobeNewswire Inc.Nicox launches AdenoPlus(R) and Xailin(TM) dry eye product range in EuropeNYSE:COXCox Comm CL A SC23
02/14/201412:34AMGlobeNewswire Inc.Nicox to re-focus naproxcinod on Duchenne muscular dystrophyNYSE:COXCox Comm CL A SC23
02/04/201412:41AMGlobeNewswire Inc.Nicox appoints Evelyne Nguyen as CFONYSE:COXCox Comm CL A SC23
01/16/201412:37AMGlobeNewswire Inc.Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North AmericaNYSE:COXCox Comm CL A SC23
01/06/20144:39PMDow Jones NewsConvergys Agrees to Acquire Stream Global ServicesNYSE:COXCox Comm CL A SC23
01/06/201412:34AMGlobeNewswire Inc.Nicox - Major Progress in 2013 in Building an International Ophthalmic CompanyNYSE:COXCox Comm CL A SC23
12/03/20137:56AMDow Jones NewsCharter Communications Doesn't Need To Make Buys, CEO Says--UpdateNYSE:COXCox Comm CL A SC23
12/03/20137:37AMDow Jones NewsCharter CEO: Charter Doesn't Need Acquisitions to Be Successful -CNBCNYSE:COXCox Comm CL A SC23
11/26/201312:50AMGlobeNewswire Inc.Nicox establishes commercial operations in Italy through acquisition of EupharmedNYSE:COXCox Comm CL A SC23
11/12/201312:48AMGlobeNewswire Inc.Nicox launches Sjo(TM) in the US and partners with the Sjogren's Syndrome FoundationNYSE:COXCox Comm CL A SC23
11/04/201312:35AMGlobeNewswire Inc.Nicox holds first ophthalmology Scientific Advisory Board and attends AAO 2013NYSE:COXCox Comm CL A SC23
10/30/20131:33AMGlobeNewswire Inc.Nicox reports financial results for the nine months to September 2013NYSE:COXCox Comm CL A SC23
09/27/20137:12AMGlobeNewswire Inc.Nicox attends Vision Expo West 2013 in Las VegasNYSE:COXCox Comm CL A SC23
09/11/201312:37AMGlobeNewswire Inc.Nicox Receives Positive Opinion for European Orphan Drug Designation for Naproxcinod for the Treatment of Duchenne Muscular D...NYSE:COXCox Comm CL A SC23
 Showing the most relevant articles for your search:NYSE:COX